Emulsions and microemulsions with a fluorocarbon phase

Current Opinion in Colloid and Interface Science

Volumn 8, Issue 3, 2003, Pages 251-258

  Krafft, Marie Pierre ^a   Chittofrati, Alba ^b   Reiss, Jean G ^c  

^a INSTITUT CHARLES SADRON   (France)

^b Solvay Solexis   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diagnosis; Drug delivery; Emulsion; Microemulsion; Oxygen delivery; Perfluorocarbon; Polymerization; Reverse emulsion; Targeted emulsion

Indexed keywords

BROMINE COMPOUNDS; DRUG PRODUCTS; MICROEMULSIONS; POLYMERIZATION;

MOLECULAR IMAGING;

FLUOROCARBONS;

AMPHOPHILE; ANGIOGENESIS INHIBITOR; BLOOD SUBSTITUTE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE MACROGOL; DOXORUBICIN; FLUORINATED HYDROCARBON; FLUOROCARBON; FLUOROLINK; GADOLINIUM; GENTAMICIN; HYDROCARBON; LIPID; MACROGOL DERIVATIVE; OXYGEN; PACLITAXEL; PERFLUORO COMPOUND; PERFLUORODECALIN; PERFLUOROOCTANOIC ACID; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; PERFLUOROPOLYETHER; PHOSPHOLIPID; POLITEF; SURFACTANT; UNCLASSIFIED DRUG; VANCOMYCIN; WATER; XENON;

BIOMEDICAL ENGINEERING; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG STABILITY; DRUG TISSUE LEVEL; EMULSION; HUMAN; IMAGING; LUNG; MEDICAL RESEARCH; METASTASIS; MICROEMULSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; REVIEW; TARGET ORGAN; TUMOR; ULTRASOUND;

EID: 0041571925     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-0294(03)00045-1     Document Type: Review

References (81)

1. Riess JG. Blood substitutes and other potential applications of fluorinated colloids. J Fluorine Chem 2002;114:119-26.
2. Riess JG. Injectable oxygen carriers (blood substitutes)-Raison d'être, chemistry, and some physiology. Chem Rev 2001;101:2797-920. A comprehensive review on blood substitute research and development with nearly 2000 references.
3. Riess JG. Blood Substitutes: The Fluorocarbon Approach. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, 2002. p. 263-79.
4. Riess JG. Fluorous micro- and nanophases with a biomedical perspective. Tetrahedron 2002;58:4113-31. A summary of the basic attributes of PFCs and F-amphiphiles that govern their self-assembly and micro- or nanophase separation behavior.
5. Krafft MP, Riess JG, Weers JG. The design and engineering of oxygen-delivering fluorocarbon emulsions. In: Benita S, editor. Submicronic Emulsions in Drug Targeting and Delivery. Amsterdam: Harwood Academic Publishers, 1998. p. 235-333.
6. Spahn DR, Waschke KF, Standl T, Motsch J, Van Huynegem L, Welte M, et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: Results of a European Phase 3 study. Anesthesiology 2002;97:1338-49. Detailed data from the latest Phase III clinical trial on use of a PFC emulsion in surgery, demonstrating avoidance and reduction of donor blood use.
7. Ivanitsky GR. Biophysics at the turn of the millennium: Perfluorocarbon media and gas-transporting blood substitutes. Biophysics 2001;46:1-31 (translated from Biofizika).
8. Riess JG. Biomedical applications of fluorous materials, In: Gladysz JA, Curran DP, Horváth I, editors. Handbook of Fluorous Chemistry, Wiley-VCH, 2003, in press.
9. Hunter N, Forster J, Chong A, McCutcheon S, Parnham D, Eaton S, et al. Transmission of prion disease by blood transfusion. J Gen Virol 2002;83:2897-905.
10. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury. J Am Med Assoc 2002;287:1968-71.
11. Brand A. Immunological aspects of blood transfusion. Transplant Immunol 2002;10:183-90.
12. Lee WL, Downey GP. ICU cornerstone: Changing our view of blood transfusions. Crit Care 2002;6:291-2.
13. Lowe KC, Farrell K, Ferguson EMP, James V. Current perceived risks of transfusion in the UK and relevance to the future acceptance of blood substitutes. Artif Cells, Blood Subst, Immob Biotech 2001;29:179-89.
14. Spahn DR, Van Brempt R, Theilmeier G, Reibold J-P, Welte M, Heinzerling H, et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthesiology 1999;91:1195-208.
15. Hill SE, Leone BJ, Faithfull NS, Flaim KE, Keipert PE, Newman MF. Perflubron emulsion (AF0144) augments harvesting of autologous blood: A phase II study in cardiac surgery. J Cardiothor Vasc Anesth 2002;16:555-60.
16. Leese PT, Noveck RJ, Shorr JS, Woods CM, Flaim KE, Keipert PE. Randomized safety studies of intravenous perflubron emulsion I. Effects on coagulation function in healthy volunteers. Anesth Analg 2000;91:804-22.
17. Noveck RJ, Shannon EJ, Leese PT, Shorr JS, Flaim KE, Keipert PE, et al. Randomized safety studies of intravenous perflubron emulsion II. Effects on immune function in healthy volunteers. Anesth Analg 2000;91:812-22.
18. Keipert PE, in: Abstracts, International Symposium on Blood Substitutes, Tokyo, Japan, 2003. p. 47.
19. Faithfull NS. The concept of hemoglobin equivalency of perfluorochemical emulsions. Adv Exp Med Biol, 2003, in press.
20. Frumento RJ, Mongero L, Naka Y, Bennett-Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesth Analg 2002;94:809-14.
21. Kaul DK, Liu X, Nagel RL. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. Blood 2001;98:3128-31.
22. Audonnet S, Fanck P, Labrude P, Krafft MP, Menu P. Improved tissue oxygenation capacity of a new generation perfluorocarbon emulsion after acute hemorrhagic shock in rabbits. Syllabus, 4th International Symposium on Current Issues of Blood Substitute Research. 2002, p. 60.
23. Jouan V, Audonnet S, Krafft MP, Gentil M, Labrude P, Stoltz JF et al. Do perfluorocarbon (PFC) emulsions modify red blood cell behavior in a hemodiluted rabbit? Syllabus, 4th International Symposium on Current Issues of Blood Substitute Research. 2002, p. 59.
24. DeRoover A, Krafft MP, Deby-Dupont G, Jacquet N, Lamy M, Meurisse M, et al. Seventy two hours hypothermic intestinal preservation study using a new perfluorocarbon emulsion. Artif Cells, Blood Subst, Immob Biotech 2001;29:225-34.
25. Marie Bertilla S, Marie P, Krafft MP. Co-surfactant effect of a semifluorinated alkane at a fluorocarbon/water interface. Impact on the stabilization of fluorocarbon-in-water emulsions, Langmuir, 2003, in press. Evidence for strong interfacial tension reduction by F-alkyl/H-alkyl diblocks at a PFC/phospholipids/water interface, providing insight into the mechanism of PFC emulsion stabilization caused by such diblocks.
26. Shchukin ED, Amelina EA, Parfenova AM. Influence of the nature of non-polar phase on the mechanical stability of adsorption layers of hydrocarbon and fluorocarbon surfactants at the interface between their aqueous solution and non-polar media. Colloids Surf A: Physicochem Eng Aspects 2001;176:35-51. A thorough experimental investigation of the role of the interfacial adsorption layers on emulsion droplet stabilization against coalescence and its dependence on a deficiency in the affinity between dispersed phase and hydrophobic tail of the emulsifier.
27. Wolber J, Rowland IJ, Leach MO, Bifone A. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon. Magn Res Med 1999;41:442-9.
28. Fan X, River JN, Zamora M, Al-Hallaq HA, Karczmar GS. Effect of carbogen on tumor oxygenation: Combined fluorine-19 and proton MRI measurements. Int J Rad Oncol Biol Phys 2002;54:1202-9.
29. Isaka M, Imamura M, Makino Y, Fukushima S, Nakai K, Shiiya N, et al. in: Abstracts, International Symposium on Blood Substitutes, Tokyo, Japan, 2003. p. 86.
30. Hsu Y-C, Peng C-A. Diminution of phagocytosed perfluorocarbon emulsions using perfluoroalkylated polyethylene glycol surfactant. Biochem Biophys Res Commun 2001;283:776-81.
31. Huang MQ, Ye Q, Williams DS, Ho C. MRI of lungs using partial liquid ventilation with water-in-perfluorocarbon emulsions. Magn Reson Med 2002;48:487-92.
32. Mathurin J-C, De Ceaurriz J, Audran M, Krafft MP. Detection of perfluorocarbons in blood by headspace solid-phase microextraction combined with gas chromatography/mass spectrometry. Biomed Chromatogr 2001;15:443-51.
33. Nomura Y, Fujii F, Sato C, Nemoto M, Tamura M. Exchange transfusion with fluorocarbon for studying synaptically evoked optical signal in rat cortex. Brain Res Brain Res Protoc 2000;5:10-5.
34. Lowe KC. Perfluorochemical respiratory gas carriers: Benefits to cell culture systems. J Fluorine Chem 2002;118:19-26.
35. Kraff MP. Fluorocarbon gels. In: Magdassi S, Touitou E, editors. Novel Cosmetic Delivery Systems. New York: Dekker, 1998, p. 195-219.
36. Babak VG, Stébé MJ. Highly concentrated emulsions: Physicochemical principles of formulation. J Disp Sci Technol 2002;23:1-15.
37. Langenfeld A, Schmitt V, Stébé MJ. Rheological behavior of fluorinated highly concentrated reverse emulsions with temperature. J Colloid Interface Sci 1999;218:522-8.
38. Van Liew HD, Burkard ME. High oxygen partial pressure in tissue delivered by stabilized microbubbles. Adv Exp Med Biol 1997;411:395-401.
39. Lundgren CEG, Bergoe GW, Tyssebotn I. in: Syllabus, 4th International Symposium on Current Issues of Blood Substitute Research, Stockholm, July 2002. p. 40.
40. Koch CJ, Oprysko PR, Shuman AL, Jenkins WT, Brandt G, Evans SM. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: A gas-phase perfluorochemical emulsion. Cancer Res 2002;62:3626-9.
41. Correas J-M, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol 2001;27:565-70.
42. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Progr Cardiovasc Dis 2001;44:13-31. An excellent introduction to molecular imaging with ultrasound or magnetic resonance using targeted PFC-in-water emulsions.
43. Lanza GM, Trousil RL, Wallace KD, Rose JH, Hall CS, Scott MJ, et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998;104:3665-72.
44. Marsh JN, Hall CS, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectrics Frequency Control 2002;49:29-38. Evaluation of an acoustic transmission line model that predicts ultrasonic reflectivity of PFC droplets bound to targeted surfaces.
45. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-40.
46. Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. J Acoust Soc Am 2000;108:3049-57.
47. Lanza GM, Abendschein DR, Hall CS, Scott MJ, Scherrer DE, Houseman A, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr 2000;13:608-14.
48. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, et al. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001;104:1280-5. Multistep in vitro and one-step in vivo MRI detection of fibrin clots, the latter using a PFC emulsion fitted with both an antifibrin monoclonal antibody and a paramagnetic gadolinium chelate.
49. Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, et al. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol 2000;35:227-34.
50. 3-targeted nanoparticles. Magn Reson Med 2000;44:433-9.
51. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation 2002;106:2842-7. An example of site-targeted drug delivery using a tissue-targeted PFC emulsion.
52. Sadtler VM, Krafft MP, Riess JG. Achieving stable, reverse water-in-fluorocarbon emulsions. Angew Chem, Int Ed Engl 1996;35:1976-8.
53. Courrier HM, Vandamme TF, Krafft MP. Reverse water-in-fluorocarbon emulsions, miniemulsions and microemulsions, 2003, in press. A range of stable macro-, mini- and microemulsions of water in PFCs, with potential for pulmonary drug delivery.
54. Sadtler VM, Krafft MP, Riess JG. Reverse water-in-fluorocarbon emulsions as a drug delivery system: An in vitro study. Colloids Surf A 1999;147:309-15.
55. Courrier HM, Vandamme TF, Krafft MP, Nakamura S, Shibata O. Mixed monolayers made from dipalmitoyl phosphatidylcholine and a fluorinated amphiphile. Colloids Surf A Physicochem Eng Aspects 2002;215:33-41.
56. Courrier HM, Krafft MP, Butz N, Porté C, Frossard N, Rémy-Kristensen A, et al. Evaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphate. Biomaterials 2003;24:689-96.
57. Butz N, Porté C, Courrier H, Krafft MP, Vandamme TF. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants. Int J Pharm 2002;238:257-69.
58. a). J Colloid Interf Sci 2003;258:354-62.
59. Franz AR, Röhlke W, Franke RP, Ebsen M, Pohlandt F, Hummler HD. Pulmonary administration of perfluorodecaline-gentamicin and perfluorodecaline-vancomycin emulsions. Am J Respir Crit Care Med 2001;164:1595-600.
60. Sjöblom J, Friberg SE. The future of microemulsions. In: Mittal KL, editor. Handbook of Microemulsion Science and Technology. New York: Marcel Dekker, 1999. p. 833-42 (Ch. 30).
61. Salager JL, Anton RE. Ionic microemulsions. In: Mittal KL, editor. Handbook of Microemulsion Science and Technology. New York: Marcel Dekker, 1999. p. 247-80 (Ch. 8). A review of the fundamentals and general formulation criteria when amphiphile and kin oil phase are involved in microemulsification.
62. Ezrahi S, Aserin A, Garti N. Aggregation behavior in one-phase (Winsor IV) microemulsion systems. In: Mittal KL, editor. Handbook of Microemulsion Science and Technology. New York: Marcel Dekker, 1999. p. 185-245 (Ch. 7). Another review that is basic to microemulsion formulation.
63. Hellweg T. Phase structures of microemulsions. Curr Opin Colloid Interface Sci 2002;7:50-6. Useful summary of recent progress on the understanding of microemulsion structuring as driven by curvature free energy and bending elastic constant of the surfactant film.
64. Olla M, Monduzzi M, Ambrosone L. Microemulsions and emulsions in DDAB/W/oil systems. Colloids Surf A 1999;160:23-36.
65. Zourab S, Al-Kashef I, Kayali I. Phase behaviour of dodecyl dimethylamino oxide/sodium dodecyl sulfate in the presence of perfluorooctanol. J Disp Sci Technol 2001;22:111-7.
66. Monduzzi M. Self-assembly in fluorocarbon surfactant systems. Curr Opin Colloid Interface Sci 1998;3:467-77.
67. Gambi CMC, Giordano R, Laurati M, Lanzi L, Pini F, Baglioni P. SANS analysis of perfluoropolyether water-in-oil microemulsion by hard sphere and adhesive hard sphere potential. Appl Phys A 2002;14(Suppl):S377-S379.
68. Senatra D, Gambi C, Carla M, Chittofrati A. Thermal behaviour of perfluoropolyether W/O percolative microemulsions. J Therm Anal Calorim 1999;56:1335-46.
69. Brubach J-B, Mermet A, Filabozzi A, Gerschel A, Lairez D, Krafft MP, et al. Dependence of water dynamics upon confinement size. J Phys Chem B 2001;105:430-5.
70. Rocca S, Stébé MJ. Mixed concentrated W/O emulsions (fluorinated/hydrogenated). J Phys Chem B 2000;104:10 490-7. A study of the phase behavior of microemulsions with two to five components; the coexistence of F- and H-microemulsions is demonstrated.
71. Ropers MH, Stébé MJ. Incorporation of fluorocarbon in fluorinated surfactant liquid crystals. Langmuir 2003;19:3137-44.
72. Baran JR. Winsor I II III microemulsion phase behavior of hydrofluoroethers and fluorocarbon/hydrocarbon catanionic surfactants. J Colloid Interface Sci 2001;234:117-21.
73. Baran JR, Decker EL, Wilcox HN. The pH-dependent surface activity of a hydrocarbon/fluorocarbon catanionic surfactant for water/hydrofluoroether microemulsions: The characterization of a new acid/soap complex. J Disp Sci Technol 2002;23:23-8.
74. Dobreva Veleva AN, Kaler EW, Schubert K-V, Feiring AE, Farnham WB. Phase behavior and microemulsion formation in compressible perfluorinated monomer oil and water mixtures. Langmuir 1999;15:4480-5.
75. LoNostro P, Choi S.-M, Ku C-Y, Chen S-H. Fluorinated microemulsions: A study of the phase transition behavior and structure. J Phys Chem B 1999;103:5347-52.
76. Rico-Lattes I, Guidetti B, Lattes A. Molecular organized systems with fluorinated compounds: From synthesis to biological applications. J Fluorine Chem 2001;107:355-1.
77. Tonelli C, Di Meo A, Fontana S, Russo A. Perfluoropolyether functional oligomers: Unusual reactivity in organic chemistry. J Fluorine Chem 2002;118:107-21.
78. Chittofrati A, D'Aprile F, Pieri R, Lenti D, Maccone P, Visca M. Perfluoropolyether carboxylic alts in micellar solution and O/W microemulsions. Progr Colloid Interface Sci (Proceedings of the XV ECIS, Coimbra, 2001) in press.
79. Giannetti E, Visca M. US Patent 486 4006, 1987.
80. Apostolo M, Arcella V, Storti G, Morbidelli M. Free radical controlled polymerisation of fluorinated copolymers produced in microemulsion. Macromolecules 2002;35:6154-66.
81. Marchetta P, Lazzarino P, Kapelliouchko V, Poggio T, Canil G, Sanguineti A, et al. PTFE nanoemulsions an ultralow-k dielectric material. Macromol Symp 2002;179:347-58.